Chairman’s AGM Presentation 2010
Again I welcome you to our 10th Annual General Meeting as a listed drug discovery and development company.
Over the past decade Deborah Rathjen and her very talented team have built an outstanding biotech company, with a highly commercial drug pipeline and an exciting drug discovery partnership with Merck Serono.
2011 is shaping up to be one of the most interesting, critical and exciting years in our brief history!
As your representative on the board, and a fellow shareholder, I want to give you a snapshot of Bionomics Limited
(ASX:BNO) today and its medium term future.
